Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken
NCT05248737 · View on ClinicalTrials.gov ↗
Study Summary
The purpose of the research is to evaluate if chicken or eggs obtained from chickens that are fed a diet that contains omega-3 fatty acids (DHA/EPA), or vitamin D (as 25(OH)D) provides additional health benefits by improving the status of omega-3 fatty acids or 25(OH)D in healthy adults who eat this bioenhanced chicken or eggs.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT DHA/EPA fortified chicken plus Placebo
- DIETARY_SUPPLEMENT non-25(OH)D fortified chicken/eggs plus vitamin D3 supplement
- DIETARY_SUPPLEMENT non-DHA bio-enhanced chicken plus supplement DHA Omega-3
- DIETARY_SUPPLEMENT 25(OH)D bioenhanced chicken and eggs plus placebo
- DIETARY_SUPPLEMENT Dietary Supplement: DHA/EPA fortified eggs plus Placebo
Study Locations (1)
New York
- Human Metabolic Research Unit — Ithaca
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2021-12-04 |
| Est. Completion | 2026-01-30 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05248737
The ClinicalTrials.gov registry entry for NCT05248737 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornell University, which has 50 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Nutrition, Healthy appearing as the primary indexed condition, and to 5 interventions — of which DHA/EPA fortified chicken plus Placebo is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05248737 reports 1 study location spanning 1 distinct geographic area — top geographies include New York. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05248737 about?
NCT05248737 is a clinical study titled "Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken". The purpose of the research is to evaluate if chicken or eggs obtained from chickens that are fed a diet that contains omega-3 fatty acids (DHA/EPA), or vitamin D (as 25(OH)D) provides additional health benefits by improving the status of omega-3 fatty acids or 25(OH)D in healthy adults who eat this...
What is the current status of trial NCT05248737?
This trial is currently active not recruiting. The enrollment target is 84 participants. The study started on 2021-12-04. Estimated completion is 2026-01-30.
What conditions does trial NCT05248737 study?
This clinical trial studies the following conditions: Nutrition, Healthy. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05248737?
The interventions under investigation include: DHA/EPA fortified chicken plus Placebo (DIETARY_SUPPLEMENT), non-25(OH)D fortified chicken/eggs plus vitamin D3 supplement (DIETARY_SUPPLEMENT), non-DHA bio-enhanced chicken plus supplement DHA Omega-3 (DIETARY_SUPPLEMENT), 25(OH)D bioenhanced chicken and eggs plus placebo (DIETARY_SUPPLEMENT), Dietary Supplement: DHA/EPA fortified eggs plus Placebo (DIETARY_SUPPLEMENT). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05248737?
This trial is sponsored by Cornell University, which has 50 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05248737 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.